<DOC>
	<DOCNO>NCT00694044</DOCNO>
	<brief_summary>1 . Characterize tolerability safety repeat dos varenicline healthy non-smoking elderly subject . 2 . Describe steady state pharmacokinetics varenicline healthy non-smoking elderly subject . 3 . Evaluate potential effect repeat dos varenicline cognition healtly non-smoking elderly subject .</brief_summary>
	<brief_title>Evaluation Varenicline Safety , Tolerability , Pharmacokinetics Pro-Cognitive Effects Healthy Elderly Non-Smoking Subjects</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy , Elderly ( 6585 year inclusive ) , Nonsmoker Creatinine Clearnace &lt; 30 ml/min , Evidence history clinically significant , unstable disease</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Safety , Tolerability , Pharmacokinetics , Cognition</keyword>
</DOC>